<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2603222-A4" country="EP" doc-number="2603222" kind="A4" date="20140101" family-id="45566699" file-reference-id="305008" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146551871" ucid="EP-2603222-A4"><document-id><country>EP</country><doc-number>2603222</doc-number><kind>A4</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-11815949-A" is-representative="NO"><document-id mxw-id="PAPP154825794" load-source="docdb" format="epo"><country>EP</country><doc-number>11815949</doc-number><kind>A</kind><date>20110811</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220419716" load-source="docdb" format="original"><country>EP</country><doc-number>11815949.0</doc-number><date>20110811</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140451664" ucid="CA-2011000908-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>CA</country><doc-number>2011000908</doc-number><kind>W</kind><date>20110811</date></document-id></priority-claim><priority-claim mxw-id="PPC140447730" ucid="CA-2712747-A" load-source="docdb"><document-id format="epo"><country>CA</country><doc-number>2712747</doc-number><kind>A</kind><date>20100811</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988102696" load-source="docdb">A61P  35/00        20060101ALI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988105480" load-source="docdb">A61P  35/02        20060101ALI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988112031" load-source="docdb">C07H  19/056       20060101ALI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988119239" load-source="docdb">A61K  31/706       20060101AFI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988121898" load-source="docdb">C07H  19/12        20060101ALI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988124841" load-source="docdb">A61K  45/06        20060101ALI20131126BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988136432" load-source="docdb">A61K  31/7056      20060101ALI20131126BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL1988116607" load-source="docdb" scheme="CPC">A61K  31/7056      20130101 LI20130816BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988127412" load-source="docdb" scheme="CPC">A61K  31/706       20130101 FI20130816BHEP        </classification-cpc><classification-cpc mxw-id="PCL1988135050" load-source="docdb" scheme="CPC">A61K  45/06        20130101 LI20130816BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132188097" lang="DE" load-source="docdb">KOMBINATORISCHE KREBSBEHANDLUNG</invention-title><invention-title mxw-id="PT132188098" lang="EN" load-source="docdb">COMBINATORY CANCER TREATMENT</invention-title><invention-title mxw-id="PT132188099" lang="FR" load-source="docdb">THÉRAPIE ANTICANCÉREUSE COMBINATOIRE</invention-title><citations><non-patent-citations><nplcit><text>B C KRALJACIC ET AL: "Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens", LEUKEMIA, vol. 25, no. 7, 1 April 2011 (2011-04-01), pages 1197 - 1200, XP055089775, ISSN: 0887-6924, DOI: 10.1038/leu.2011.57</text><sources><source mxw-id="PNPL67415204" load-source="docdb" name="SEA" category="XPI"/></sources></nplcit><nplcit><text>S. ASSOULINE ET AL: "Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin", BLOOD, vol. 114, no. 2, 11 May 2009 (2009-05-11), pages 257 - 260, XP055089784, ISSN: 0006-4971, DOI: 10.1182/blood-2009-02-205153</text><sources><source mxw-id="PNPL67415205" load-source="docdb" name="SEA" category="A"/></sources></nplcit><nplcit><text>See also references of WO 2012019284A1</text><sources><source mxw-id="PNPL67415206" load-source="docdb" name="SEA"/></sources></nplcit><nplcit><text>TAN K ET AL: "Ribavirin targets eIF4E dependent Akt survival signaling", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 375, no. 3, 24 October 2008 (2008-10-24), pages 341 - 345, XP025398752, ISSN: 0006-291X, [retrieved on 20080814], DOI: 10.1016/J.BBRC.2008.07.163</text><sources><source mxw-id="PNPL67415207" load-source="docdb" name="SEA" category="A"/></sources></nplcit><nplcit><text>ZHU XIONGPENG ET AL: "Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights", JOURNAL OF HEMATOLOGY &amp; ONCOLOGY, BIOMED CENTRAL LTD, LONDON UK, vol. 3, no. 1, 23 April 2010 (2010-04-23), pages 17, XP021083343, ISSN: 1756-8722, DOI: 10.1186/1756-8722-3-17</text><sources><source mxw-id="PNPL67415208" load-source="docdb" name="SEA" category="ID"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918155261" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>UNIV MONTREAL</last-name><address><country>CA</country></address></addressbook></applicant><applicant mxw-id="PPAR918155042" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>UNIVERSITE DE MONTREAL</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918140189" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>BORDEN KATHERINE</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR918144394" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BORDEN, KATHERINE</last-name></addressbook></inventor><inventor mxw-id="PPAR918143452" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>CULJKOVIC BILJANA</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR918138501" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>CULJKOVIC, BILJANA</last-name></addressbook></inventor></inventors></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS548940261" load-source="docdb">AL</country><country mxw-id="DS548926258" load-source="docdb">AT</country><country mxw-id="DS548939912" load-source="docdb">BE</country><country mxw-id="DS548943231" load-source="docdb">BG</country><country mxw-id="DS548842248" load-source="docdb">CH</country><country mxw-id="DS548939913" load-source="docdb">CY</country><country mxw-id="DS548926259" load-source="docdb">CZ</country><country mxw-id="DS548940262" load-source="docdb">DE</country><country mxw-id="DS548939918" load-source="docdb">DK</country><country mxw-id="DS548939919" load-source="docdb">EE</country><country mxw-id="DS548950420" load-source="docdb">ES</country><country mxw-id="DS548943232" load-source="docdb">FI</country><country mxw-id="DS548842249" load-source="docdb">FR</country><country mxw-id="DS548940263" load-source="docdb">GB</country><country mxw-id="DS548939920" load-source="docdb">GR</country><country mxw-id="DS548940264" load-source="docdb">HR</country><country mxw-id="DS548926260" load-source="docdb">HU</country><country mxw-id="DS548950421" load-source="docdb">IE</country><country mxw-id="DS548939921" load-source="docdb">IS</country><country mxw-id="DS548943233" load-source="docdb">IT</country><country mxw-id="DS548939926" load-source="docdb">LI</country><country mxw-id="DS548943238" load-source="docdb">LT</country><country mxw-id="DS548819565" load-source="docdb">LU</country><country mxw-id="DS548943239" load-source="docdb">LV</country><country mxw-id="DS548943240" load-source="docdb">MC</country><country mxw-id="DS548819566" load-source="docdb">MK</country><country mxw-id="DS548819567" load-source="docdb">MT</country><country mxw-id="DS548950422" load-source="docdb">NL</country><country mxw-id="DS548870733" load-source="docdb">NO</country><country mxw-id="DS548950423" load-source="docdb">PL</country><country mxw-id="DS548943241" load-source="docdb">PT</country><country mxw-id="DS548926261" load-source="docdb">RO</country><country mxw-id="DS548943334" load-source="docdb">RS</country><country mxw-id="DS548950424" load-source="docdb">SE</country><country mxw-id="DS548842250" load-source="docdb">SI</country><country mxw-id="DS548870734" load-source="docdb">SK</country><country mxw-id="DS548870735" load-source="docdb">SM</country><country mxw-id="DS548819568" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
